Back to results
CompletedPhase 2

Docetaxel, Gemcitabine and Bevacizumab for Metastatic Breast Cancer

NCT00754351

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

University Hospital of Crete, Dep of Medical Oncology

Heraklion, Crete, Greece

+1 additional location

View on ClinicalTrials.gov
Docetaxel, Gemcitabine and Bevacizumab for Metastatic Breast Cancer — TrialFind